The largest database of trusted experimental protocols

213 protocols using l glutamic acid

1

Microinjections of Glutamate, GABA, and Antagonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male and female juvenile rats (32-33 days of age) received a single 0.5 μl injection of Ringer’s solution (vehicle) or one of the following drugs or cocktails: the non-specific glutamate receptor agonist L-glutamic acid (600 nmol; Sigma Aldrich, St. Louis, MO), the V1aR antagonist (CH2)5Tyr(Me2)AVP (10ng), a cocktail containing the V1aR antagonist d(CH2)5Tyr(Me2)AVP (10ng) and L-glutamic acid (600nmol), a cocktail containing the V1aR antagonist d(CH2)5Tyr(Me2)AVP (10ng), NMDA receptor antagonist AP-5 (2 mM; Sigma Aldrich, St. Louis, MO), and AMPA receptor antagonist CNQX (0.4 mM; Sigma Aldrich, St. Louis, MO), or the selective GABA-A receptor agonist muscimol (100 ng; Sigma Aldrich, St. Louis, MO). Each rat received one vehicle injection and one drug injection in a counterbalanced order over two consecutive days. Drug doses were chosen based on previous microinjection studies in rats inducing changes in behavior (Veenema et al., 2012 (link), 2013 (link); Bredewold et al., 2015 (link); Stanley et al., 1993; Numan et al., 2010).
+ Open protocol
+ Expand
2

Neuroinflammation Modulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipopolysaccharide (LPS; Sigma-Aldrich), the system xC inhibitor SSZ (Sigma-Aldrich), and l-glutamic acid (Sigma-Aldrich) were prepared in accordance with manufacturer's recommendations in PBS, 1 M NH4OH, and PBS, respectively, and administered at doses of 1 µg/mL (LPS), 200 µM (SSZ), and 300 mM (l-glutamic acid).
+ Open protocol
+ Expand
3

Neuroprotective Effects of Mdivi-1 on Glutamate-Induced Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neurons isolated from neonatal rats were randomly divided into four groups: control, dimethyl sulfoxide, glutamate, and Mdivi-1 + glutamate. Cells in the control group were left untreated. In the dimethyl sulfoxide group, cells were cultured in medium containing dimethyl sulfoxide (the ratio of dimethyl sulfoxide to medium was 1:200; Sigma). Cells in the glutamate and Mdivi-1 + glutamate groups were treated with 10 mM L-glutamic acid (Sigma, Shanghai, China) for 24 hours (Zhu et al., 2017); cells in the Mdivi-1 + glutamate group were pretreated with 50 μM Mdivi-1 (Sigma) for 2 hours before addition of L-glutamic acid.
+ Open protocol
+ Expand
4

Pharmacological Evaluation of Analgesic Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs and chemicals were used in the current study: morphine sulphate, diclofenac sodium, naloxone (Hameln Pharmaceuticals GmbH), acetic acid, methanol, formalin, cinnamaldehyde, methylene blue, L-glutamic acid (Merck, Germany), glibenclemide (Square Pharmaceuticals Ltd., Bangladesh), and DMSO (Merck, Germany).
+ Open protocol
+ Expand
5

Pharmaceutical Preparation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Diclofenac sodium and glibenclamide were purchased from Square Pharmaceuticals Ltd. (Dhaka, Bangladesh). Methanol, 99% dimethylsulfoxide (DMSO), l-glutamic acid, acetic acid, and formalin were procured from Merck (Darmstadt, Germany).
+ Open protocol
+ Expand
6

Analytical Procedures for Flavor Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hexanal, trans-hex-2-enal, trans-hept-2-enal, trans-oct-2-enal, trans-non-2-enal, trans-dec-2-enal, trans-undec-2-enal (≥95%), trans,trans-nona-2,4-dienal, trans,trans-deca-2,4-dienal, trans,trans-undeca-2,4-dienal (≥90%), cis-dec-4-enal, cis-undec-8-enal, hexan-2-one, heptan-2-one, nonan-2-one, 2-butyloct-2-enal, dl-alanine, l-glutamic acid, and ethanolamine were obtained from Merck KGaA, Darmstadt, Germany. Butan-2-one (>99%), pentan-2-one (>99%), octan-2-one (>98%), decan-2-one (>99%), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (>96%), and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine were obtained from TCI Chemicals Europe N.V., Zwijndrecht, Belgium. l-Glycine, l-lysine, dl-leucine, and γ-aminobutyric acid (97%) were obtained from Fisher Scientific GmbH, Schwerte, Germany. Paraffin oil (Pfeiffer® P3) was obtained from MasCom Technologies GmbH, Bremen, Germany. Headspace vials (20 mL) and magnetic screw caps with a septum (SIL/PTFE 1.9 mm) were purchased from Chromatographie-Zubehör Trott, Kriftel, Germany. Fats and vegetable oils were purchased from local supermarkets. All chemicals were of analytical grade, if not mentioned otherwise.
+ Open protocol
+ Expand
7

Development of a μPAD Sensor

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reagents used were of analytical reagent grade unless stated otherwise and were obtained from Sigma-Aldrich (Sigma-Aldrich Química S.A., Madrid, Spain). All aqueous solutions were made using reverse osmosis-type quality water, Milli-RO 12 plus Milli-Q station from Millipore, with a conductivity of 18.2 MΩ·cm (Millipore, Bedford, MA, USA). 3,3′,5,5′-tetramethylbenzidine (TMB) (CAS No, 54827-17-7); acetic acid (CAS No, 64-19-7); sodium acetate (CAS No, 127-09-3); ethanol (CAS No, 64-17-5); L-glutathione (GSH) (CAS No, 70-18-8); L-cysteine (Cys) (CAS No, 7048-04-6); L-glutamine (Gln) (CAS No, 56-85-9); L-arginine (Arg) (CAS No, 74-79-3); L-asparagine (Asn) (CAS No, 70-47-3); DL-homocysteine (Hcys) (CAS No, 454-29-5); L-glutamic acid (Glu) (CAS No, 56-86-0); D-mannose (Man) (CAS No, 3458-28-4); galactose (Gal) (CAS No, 137868-52-1); D-lysine (Lys) (CAS No, 923-27-3); L-serine (Ser) (CAS No, 56-45-1); L-histidine (His) (CAS No, 71-00-1); Bovine serum albumin (BSA) (CAS No, 9048-46-8); and Silver nitrate (AgNO3) (CAS No, 7761-88-8) were acquired from Merck (Darmstadt, Germany). Filter paper (ref. Whatman 1, qualitative circles 150 mm) from Sigma-Aldrich and 54 × 86 mm transparent sheets with a quality strength protection of 125 microns (Fellowes® pouches, Itaca, NY, USA) were used to prepare and laminate the μPAD.
+ Open protocol
+ Expand
8

Pharmacological Effects Evaluation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Morphine sulfate was purchased from TEMAD Co. (Tehran, Iran). Naltrexone hydrochloride and ondansetron hydrochloride were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). NaCl and L-glutamic acid were purchased from Merck Chemicals Co. (Darmstadt, Germany). All drugs and chemicals were dissolved in physiological saline, and just only NaCl dissolved in distilled water.
+ Open protocol
+ Expand
9

Pharmacological Evaluation of Analgesic Drugs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The drugs and chemicals used in this study are: diclofenac sodium (Novartis Bangladesh Ltd.), morphine sulfate, sodium thiopental (Gonoshasthaya Pharmaceuticals Ltd.), diazepam (Square Pharmaceuticals Ltd.), naloxone hydrochloride (Samarth Life Sciences Pvt. Ltd., India), methanol, acetic acid, formalin, L-glutamic acid (Merck, Germany).
+ Open protocol
+ Expand
10

Intracellular Metabolite Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sedoheptulose 7-phosphate and erythrose 4-phosphate were purchased from Carbosynth, cysteinylglycine from Bachem AG, and l-aspartic acid, citric acid monohydrate, l-glutamic acid, l-glutamine, glycine, l-leucine, dl-malic acid, l-methionine and l-valine from Merck. All other standard substances were obtained from Sigma Aldrich. A mix of 82 relevant intracellular metabolites was prepared from standard substances. Single standard solutions of each metabolite were obtained by exact weighing and dissolving the standard substance in a suitable solvent (0.1 M hydrochloric acid, 0.1 M sodium hydroxide or water). Equimolar mixtures of the 82 metabolites were used for initial method development. For the use as calibration standards, appropriate dilutions of equimolar stock mixes of the 82 metabolites were spiked with a defined volume of uniformly 13C-labeled yeast cell extract (prepared in-house42 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!